A recent study provides clinicians genomic guidance for surveillance of targeted therapy resistance in patients with EGFR-mutant non-small cell lung cancer — and more importantly — another drug option when resistance occurs.
News: Home Page Feature
The 20th Annual Scientific Retreat will be held Wednesday, May 1, 8:30 a.m. to 3 p.m., at the Vanderbilt University Student Life Center. Registration is free, but attendees should register by April 26. The topic of the retreat is “Signal Transduction in Cancer Initiation, Progression and Treatment.”
The Vanderbilt-Ingram Cancer Center Department of Radiation Oncology is offering survivorship care in Clarksville, Tennessee, via telemedicine to patients after they complete curative treatment.
For the 10th year in a row Vanderbilt University Medical Center (VUMC) and Vanderbilt-Ingram Cancer Center (VICC) have been named a CEO Cancer Gold Standard employer by the CEO Roundtable on Cancer.
Feeling Good in Your Own Skin is a free educational event for patients, caregivers and survivors to learn about advancements in melanoma research, clinical care, and survivorship.
The VU Breast Health Cool Springs clinic, located at 324 Cool Springs Blvd., Suite B, Franklin, provides a range of medical services for individuals at high risk for developing breast cancer.
Lung cancer is the most deadly cancer in the United States – but high-tech imaging now lets smokers get checked for early signs of lung cancer. Finding lung cancer in its earliest stages makes it far easier to treat.
Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system. The Neurofibromatosis Patient and Family Symposium will be held Saturday, April 21, 9 a.m. – 1 p.m., at the VICC 8th floor conference center in the Preston Research Building, 2220 Pierce Ave.
Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology, has formed the HPV-Associated Cancer Consortium Vanderbilt (HPVACTIVE) program to raise awareness and provide community-wide education about HPV-associated cancers.
Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram Cancer Center (VICC) have announced a new collaboration to improve outcomes for cancer patients.